NCT05172245 2026-04-17Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerNational Cancer Institute (NCI)Phase 1 Recruiting46 enrolled
NCT05063552 2026-04-13Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck CancersNational Cancer Institute (NCI)Phase 2/3 Active not recruiting430 enrolled